NIOX Group PLC (NIOX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.130x

Based on the latest financial reports, NIOX Group PLC (NIOX) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX8.80 Million ≈ $1.07K USD) by net assets (GBX67.60 Million ≈ $8.22K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NIOX company net worth for the company's overall valuation and market capitalisation.

NIOX Group PLC - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how NIOX Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NIOX Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NIOX Group PLC ranked by their cash flow conversion efficiency. Explore NIOX Group PLC (NIOX) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Datadot Technology Ltd
AU:DDT
-0.008x
H&T Group plc
LSE:HAT
0.033x
New Sources Energy N.V
AS:NSE
0.001x
Odd Burger Corp
V:ODD
0.012x
NextEnergy Solar Fund Ltd
LSE:NESF
0.038x
Pearl Polymers Limited
NSE:PEARLPOLY
-0.121x
Century Global Commodities Corp
TO:CNT
-0.047x
Maple Peak Investments Inc
V:MAP
-0.062x

Annual Cash Flow Conversion Efficiency for NIOX Group PLC (2013–2025)

The table below shows the annual cash flow conversion efficiency of NIOX Group PLC from 2013 to 2025. View NIOX share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX67.60 Million
≈ $8.22K
GBX15.80 Million
≈ $1.92K
0.234x -19.15%
2024-12-31 GBX59.50 Million
≈ $7.24K
GBX17.20 Million
≈ $2.09K
0.289x +108.83%
2023-12-31 GBX83.80 Million
≈ $10.20K
GBX11.60 Million
≈ $1.41K
0.138x 0.00%
2023-12-30 GBX83.80 Million
≈ $10.20K
GBX11.60 Million
≈ $1.41K
0.138x +69.21%
2022-12-31 GBX81.90 Million
≈ $9.96K
GBX6.70 Million
≈ $815.20
0.082x 0.00%
2022-12-30 GBX81.90 Million
≈ $9.96K
GBX6.70 Million
≈ $815.20
0.082x +290.34%
2021-12-31 GBX66.80 Million
≈ $8.13K
GBX1.40 Million
≈ $170.34
0.021x 0.00%
2021-12-30 GBX66.80 Million
≈ $8.13K
GBX1.40 Million
≈ $170.34
0.021x +105.80%
2020-12-31 GBX66.10 Million
≈ $8.04K
GBX-23.90 Million
≈ $-2.91K
-0.362x 0.00%
2020-12-30 GBX66.10 Million
≈ $8.04K
GBX-23.90 Million
≈ $-2.91K
-0.362x -22.16%
2019-12-31 GBX84.80 Million
≈ $10.32K
GBX-25.10 Million
≈ $-3.05K
-0.296x 0.00%
2019-12-30 GBX84.80 Million
≈ $10.32K
GBX-25.10 Million
≈ $-3.05K
-0.296x -33.41%
2018-12-31 GBX183.00 Million
≈ $22.27K
GBX-40.60 Million
≈ $-4.94K
-0.222x 0.00%
2018-12-30 GBX183.00 Million
≈ $22.27K
GBX-40.60 Million
≈ $-4.94K
-0.222x -43.13%
2017-12-31 GBX371.60 Million
≈ $45.21K
GBX-57.60 Million
≈ $-7.01K
-0.155x 0.00%
2017-12-30 GBX371.60 Million
≈ $45.21K
GBX-57.60 Million
≈ $-7.01K
-0.155x +14.54%
2016-12-31 GBX312.60 Million
≈ $38.03K
GBX-56.70 Million
≈ $-6.90K
-0.181x 0.00%
2016-12-30 GBX312.60 Million
≈ $38.03K
GBX-56.70 Million
≈ $-6.90K
-0.181x -43.32%
2015-12-31 GBX440.90 Million
≈ $53.64K
GBX-55.80 Million
≈ $-6.79K
-0.127x 0.00%
2015-12-30 GBX440.90 Million
≈ $53.64K
GBX-55.80 Million
≈ $-6.79K
-0.127x +34.56%
2014-12-31 GBX190.80 Million
≈ $23.21K
GBX-36.90 Million
≈ $-4.49K
-0.193x 0.00%
2014-12-30 GBX190.80 Million
≈ $23.21K
GBX-36.90 Million
≈ $-4.49K
-0.193x +67.50%
2013-12-31 GBX30.05 Million
≈ $3.66K
GBX-17.88 Million
≈ $-2.18K
-0.595x 0.00%
2013-12-30 GBX30.05 Million
≈ $3.66K
GBX-17.88 Million
≈ $-2.18K
-0.595x --

About NIOX Group PLC

LSE:NIOX UK Medical Devices
Market Cap
$3.43 Million
GBX28.20 Billion GBX
Market Cap Rank
#29344 Global
#563 in UK
Share Price
GBX67.00
Change (1 day)
+0.00%
52-Week Range
GBX54.40 - GBX76.00
All Time High
GBX306.79
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more